Acuitas Investments LLC Buys New Stake in KORU Medical Systems, Inc. $KRMD

Acuitas Investments LLC bought a new stake in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) in the 2nd quarter, Holdings Channel reports. The institutional investor bought 402,494 shares of the company’s stock, valued at approximately $1,441,000.

Several other institutional investors also recently bought and sold shares of the stock. Goldman Sachs Group Inc. grew its stake in KORU Medical Systems by 189.5% during the first quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock valued at $617,000 after acquiring an additional 158,914 shares in the last quarter. Russell Investments Group Ltd. grew its stake in shares of KORU Medical Systems by 220.5% in the 1st quarter. Russell Investments Group Ltd. now owns 214,908 shares of the company’s stock worth $546,000 after buying an additional 147,857 shares in the last quarter. Jane Street Group LLC grew its stake in shares of KORU Medical Systems by 136.7% in the 1st quarter. Jane Street Group LLC now owns 163,137 shares of the company’s stock worth $414,000 after buying an additional 94,214 shares in the last quarter. OMERS ADMINISTRATION Corp purchased a new position in shares of KORU Medical Systems in the 1st quarter worth $239,000. Finally, Calamos Advisors LLC grew its stake in shares of KORU Medical Systems by 36.5% in the 1st quarter. Calamos Advisors LLC now owns 88,718 shares of the company’s stock worth $225,000 after buying an additional 23,729 shares in the last quarter. 58.60% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of KORU Medical Systems in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, KORU Medical Systems presently has an average rating of “Moderate Buy” and an average price target of $4.63.

KORU Medical Systems Price Performance

KRMD stock opened at $4.25 on Friday. KORU Medical Systems, Inc. has a 12 month low of $1.86 and a 12 month high of $5.05. The company has a current ratio of 2.91, a quick ratio of 2.25 and a debt-to-equity ratio of 0.01. The company has a 50-day moving average price of $4.08 and a 200 day moving average price of $3.44. The stock has a market cap of $196.52 million, a PE ratio of -47.22 and a beta of 0.49.

KORU Medical Systems (NASDAQ:KRMD) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.01 EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.04. KORU Medical Systems had a negative net margin of 12.24% and a negative return on equity of 26.77%. The firm had revenue of $10.20 million during the quarter, compared to analysts’ expectations of $9.46 million. Equities research analysts anticipate that KORU Medical Systems, Inc. will post -0.13 earnings per share for the current year.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.